Hello, Welcome to Shine Consultant !
Summit & Event Advisor & Insight Research & Analysis
Conference Sponsor
2020 - 12 - 10
CrownBio is a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular, and metabolic disease research.Founded in 2006, CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today’s most advanced drug development challenges.Our portfolio translational platforms provide insight and understanding about a drug’s efficacy, pharmacological profile, and patient response profile. This reduce failure in the clinic and supports the selection of the right patients for the right therapy.CrownBio’s fast-paced R&D programs are yielding novel, yet well-validated models at the cutting-edge of disease research.In 2018, JSR Corporation acquired Crown Bioscience to be a strategic part of its global JSR Life Sciences division.
2020 - 11 - 20
Sichuan Kangcheng Biotechnology is a pre-clinical drug discovery contract research organization (CRO) located in the prosperous and time-honored city of Chengdu in Southwestern China. Founded and affiliated with Sichuan University West China Hospital, Kangcheng continues to develop innovative animal disease models ranging from rodents to non-human primates,including Cardiovascular diseases, CNS diseases, oncology, metabolic diseases, Ophthalmic diseases, Autoimmune diseases, Liver and Kidney diseases. We are particularly strong on minimally-invasive catheterization for cardio-cerebral vascular diseases, patient-derived xenograft models, molecular imaging, neurological studies augmented with automated behavioral assessment, dynamic CSF sampling from cisterna magna and gut microbiome studies. With a highly professional team, state-of-the-art equipment, and AAALAC-accredited animal facilities, we provide standard or customized preclinical screening or efficacy evaluation services to our domestic and international customers.  We have helped many clients win IND approval in both China and USA.
2020 - 11 - 12